B. Riley Wealth Advisors, Inc. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
B. Riley Wealth Advisors, Inc. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$55,000
-50.5%
31,685
+2.8%
0.00%
-50.0%
Q1 2022$111,000
-43.4%
30,815
-21.4%
0.00%
-33.3%
Q4 2021$196,000
-33.8%
39,207
-4.9%
0.01%
-33.3%
Q3 2021$296,000
-31.5%
41,220
-11.5%
0.01%
-35.7%
Q2 2021$432,000
-38.0%
46,570
-37.9%
0.01%
-44.0%
Q1 2021$697,000
+79.6%
75,011
+71.3%
0.02%
+19.0%
Q4 2020$388,000
+70.9%
43,780
+148.0%
0.02%
+75.0%
Q3 2020$227,000
-37.1%
17,653
+32.0%
0.01%
-50.0%
Q2 2020$361,000
-86.6%
13,376
+5250.4%
0.02%
+2300.0%
Q2 2014$2,703,0002500.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Round Table Services, LLC 339,391$1,887,0000.64%
ARK Investment Management 1,917,071$10,659,0000.32%
WASATCH ADVISORS LP 4,767,879$26,509,0000.30%
Wellington Shields & Co., LLC 48,000$267,0000.14%
Virtus ETF Advisers LLC 104,004$578,0000.06%
BREWIN DOLPHIN LTD 59,123$328,7240.04%
Wellington Shields Capital Management, LLC 30,600$170,0000.03%
GLENVIEW STATE BANK TRUST DEPT. 10,000$56,0000.02%
IHT Wealth Management, LLC 16,273$90,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 227,599$1,265,0000.02%
View complete list of INOVIO PHARMACEUTICALS INC shareholders